Chronic fatigue syndrome: Identification of distinct subgroups on the basis of allergy and psychologic variables

Journal of Allergy and Clinical Immunology

Volumn 102, Issue 2, 1998, Pages 222-230

  Borish, Larry ^a   Schmaling, Karen ^b   DiClementi, Jeannie D ^a   Streib, Joanne ^a   Negri, Julie ^a   Jones, James F ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Allergic; Chronic fatigue syndrome; Cytokines; IL 10; Psychologic morbidity; Tumor necrosis factor

Indexed keywords

ALPHA INTERFERON; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; FATIGUE; FEMALE; HUMAN; INFLAMMATION; MALE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; SYMPTOMATOLOGY;

EID: 0031754489     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(98)70090-9     Document Type: Article

References (32)

1. Olson GB, Kanaan MN, Geoffrey MG, Kelley LM, Jones JF. Correlation between allergy and persistent Epstein-Barr virus infections in chronic-active Epstein-Barr virus-infected patients. J Allergy Clin Immunol 1986;78:308-14.
2. Straus SE, Dale JK, Wright R, Metcalfe DD. Allergy and the chronic fatigue syndrome. J Allergy Clin Immunol 1988;81:791-5.
3. Steinberg P, McNutt BE, Marshall P. Double-blind placebo-controlled study of the efficacy of oral terfenadine in the treatment of chronic fatigue syndrome. J Allergy Clin Immunol 1996;97:119-26.
4. Cleveland CH Jr, Fisher RH, Brestel EP, Esinhart JD, Metzger WJ. Chronic rhinitis: an underrecognized association with fibromyalgia. Allergy Proc 1992;13:263-7.
5. Conti F, Magrini L, Priori R, Valesini G, Bonini S. Eosinophil cationic protein serum levels and allergy in chronic fatigue syndrome. Allergy 1996;51:124-7.
6. Cheney PR, Dorman SE, Bell DS. Interleukin-2 and the chronic fatigue syndrome [letter]. Ann Intern Med 1989;110:321.
7. Straus SE, Dale JK, Peter JB, Dinarello CA. Circulating lymphokine levels in the chronic fatigue syndrome. J Infect Dis 1989;160:1085-6.
8. Chao CC, Janoff EN, Hu S. Altered cytokine release in peripheral blood mononuclear cell cultures from patients with the chronic fatigue syndrome. Cytokine 1991;3:292-8.
9. Patarca R, Klimas NG, Lugtendorf S, Antoni M, Fletcher MA. Dysregulated expression of tumor necrosis factor in chronic fatigue syndrome: interrelations with cellular sources and patterns of soluble immune mediator expression. Clin Infect Dis 1991;18(Suppl 1):S147-53.
10. Chao CC, Gallagher M, Phair J, Peterson PK. Serum neopterin and interleukin-6 levels in chronic fatigue syndrome. Infect Dis 1990;162:1412-3.
11. Lloyd AR. Immunological studies of chronic fatigue syndrome. Clin Infect Dis 1994;18(Suppl 1):S134-5.
12. Linde A, Andersson B, Svenson SB. Serum levels of lymphokines and soluble cellular receptors in primary Epstein-Barr virus infection and in patients with chronic fatigue syndrome. J Infect Dis 1992;165:994-1000.
13. Ho-Yen DO, Carrington D, Armstrong AA. Myalgic encephalomyelitis and α-interferon. Lancet 1988;1:125.
14. Holmes GP, Kaplan JE, Gantz NM. Chronic fatigue syndrome: a working case definition. Ann Intern Med 1988;108:387-9.
15. Fontaine S, Damais C, Lando D, Cousin M-A. Monoclonal antibodies to human interleukin-1β and their use in a sensitive two-site enzyme linked immunosorbent assay. Lymphokine Res 1989;8:129-40.
16. Abrams JS, Roncarolo M-G, Yssel H, Andersson U, Gleich GJ, Silver JE. Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol Rev 1992;127:5-24.
17. Brenner CA, Tam AW, Nelson PA. Message amplification phenotyping (MAPPing): a technique to simultaneously measure multiple mRNAs from small numbers of cells. Biotechniques 1989;7:1096-103.
18. Robins LN, Heizer JE, Croughan J, Ratcliff KS. The NIMH Diagnostic Interview Schedule: its history, characteristics, and validity. Arch Gen Psych 1981;38:381-9.
19. Spitzer RL, Williams JBW, Gibbon M, First MB. Structured clinical interview for DMS-III-R personality disorder (SCID-II). New York: Biometrics Research Dept, NY State Psychiatric Institute; 1989.
20. Derogatis LR. SCL-90R: administration, scoring, and procedures. Riderwood, Maryland: Clinical Psychometric Research; 1975.
21. Marshall PS. Allergy and depression: a neurochemical threshold model of the relation between the illnesses. Psychol Bull 1993;113:23-43.
22. Cannon JG, Nerad JL, Poutsiaka DD, Dinarello CA. Measuring circulating cytokines. J Appl Physiol 1993;75:1897-902.
23. Matsushima K, Taguchi M, Kovacs EJ, Young HA, Oppenheim JJ. Intracellular localization of human monocyte-associated interleukin 1 (IL 1) activity and release of biologically active IL 1 from monocytes by trypsin and plasmin. J Immunol 1986;136:2883-91.
24. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989;170:2081-95.
25. + T cell clones and resting T cells: specific inhibition of IL-2 production and proliferation. J Immunol 1993;150:4754-65.
26. + T cell clones and peripheral blood T cells. J Immunol 1992;149:2378-84.
27. Malefyt Rd, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-20.
28. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147:3815-22.
29. Ralph P, Nakoinz I, Sampson-Johannes A, Fong S, Lowe D, Min H-Y, et al. IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. J Immunol 1992;148:808-14.
30. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin 10. J Exp Med 1991;174:1549-55.
31. D'Andrea A, Aste-Amezaga M, Vaiante NM, Ma X, Kubin M, Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon-g production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 1993;178:1041-8.
32. Russo J, Katon W, Sullivan M, Clark M, Buchwald D. Severity of somatization and its relationship to psychiatric disorders and personality. Psychosomatics 1994;35:546-56.